Top Markets
#1 Prom Prom +36.71%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +29.37%
#4 UnifAI Network UnifAI Network +29.28%
#5 GEKKO GEKKO +23.69%
#6 MarsCoin MarsCoin +22.62%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +20.59%
#8 Kinesis Silver Kinesis Silver +19.20%
#9 Versatize Coin Versatize Coin +16.67%
#10 Derive Derive +14.36%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
Onward Medical N.V. Onward Medical N.V.

Onward Medical N.V.

ONWD
Rank in Stocks #20498
Onward Medical N.V. is a medical technology company dedicated to developing... Onward Medical N.V. is a medical technology company dedicated to developing innovative therapies for spinal cord injuries, operating both within the Netherlands and internationally. Among its primary offerings is ARCEX, a non-invasive, external platform. This system incorporates a wearable stimulator and a wireless programmer, designed to restore or significantly enhance hand and arm motor function for individuals living with spinal cord injuries. Complementing this is ARCIM, an implantable platform. ARCIM features an implantable pulse generator and a lead positioned near the spinal cord, empowering individuals with chronic paralysis to regain the ability to stand and walk, often with minimal or no external assistance. The company is also currently advancing the Up-LIFT Trial, a clinical study evaluating the safety and efficacy of ARCEX Therapy in restoring strength and mobility in the upper extremities of those affected by spinal cord injury. Established in 2014, Onward Medical N.V. maintains its headquarters in Eindhoven, Netherlands.
Share Price
$2.76
Market Cap
$128.99M
Change (1 day)
-1.69%
Change (1 year)
-53.40%
Country
NL
Trade Onward Medical N.V. (ONWD)

Category

Healthcare
P/E ratio for Onward Medical N.V. (ONWD)
P/E ratio as of 2026 TTM: 0
According to Onward Medical N.V. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Onward Medical N.V. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 29.20 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 30.62 -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 -7.93 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 32.46 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.